Precision Biosciences officer reports equity holdings
Mei Zhang Lu, Chief Accounting Officer of Precision Biosciences Inc, reports direct ownership of 5,115 shares of common stock.
Rhea-AI Filing Summary
Mei Zhang Lu, Chief Accounting Officer of Precision Biosciences Inc, reports direct ownership of 5,115 shares of common stock. She also holds fully vested employee stock options covering 945, 214, 403 and 778 shares at exercise prices of 378.0000, 174.9000, 340.2000 and 122.4000, expiring between 2029 and 2032, plus restricted stock units covering 11,288 and 30,129 shares that vest in three substantially equal annual installments beginning on February 24, 2026 and February 22, 2027, respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Burris Mei Zhang Lu
Role
Chielf Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Restricted Stock Units F3, F2 | -- | -- | -- |
| holding | Restricted Stock Units F3, F4 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 2,340 contracts (Direct);
Restricted Stock Units — 41,417 contracts (Direct);
Common Stock — 5,115 shares (Direct)
Footnotes (4)
- F1. The stock options are fully vested and exercisable as of the date of this report.
- F2. On July 24, 2025, the reporting person was granted 16,932 restricted stock units ("RSUs"), which vest in three substantially equal annual installments beginning on February 24, 2026, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
- F3. The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.
- F4. On June 1, 2026, the reporting person was granted 30,129 RSUs, which vest in three substantially equal annual installments beginning on February 22, 2027, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
Key Figures
Common stock held: 5,115 shares
Option at 378.0000: 945 underlying shares; 378.0000 exercise price
Option at 174.9000: 214 underlying shares; 174.9000 exercise price
+4 more
7 metrics
Common stock held
5,115 shares
Direct ownership as of 2026-08-01
Option at 378.0000
945 underlying shares; 378.0000 exercise price
Fully vested employee stock option expiring 2029-05-01
Option at 174.9000
214 underlying shares; 174.9000 exercise price
Fully vested employee stock option expiring 2030-08-20
Option at 340.2000
403 underlying shares; 340.2000 exercise price
Fully vested employee stock option expiring 2031-06-06
Option at 122.4000
778 underlying shares; 122.4000 exercise price
Fully vested employee stock option expiring 2032-03-02
RSUs from 2025 grant
11,288 RSUs from 16,932-unit grant
Grant dated 2025-07-24, vesting in three annual installments from 2026-02-24
RSUs from 2026 grant
30,129 RSUs
Grant dated 2026-06-01, vesting in three annual installments from 2027-02-22
Key Terms
Employee Stock Option (Right to Buy), Restricted Stock Units, contingent right to receive one share, substantially equal annual installments
4 terms
Employee Stock Option (Right to Buy) financial
"Security title listed as Employee Stock Option (Right to Buy)"
Restricted Stock Units financial
"Security title listed as Restricted Stock Units linked to common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
substantially equal annual installments financial
"RSU grants vest in substantially equal annual installments over three years"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity holdings does Mei Zhang Lu report in DTIL?
Mei Zhang Lu reports 5,115 common shares held directly, fully vested stock options on 945, 214, 403 and 778 shares, and restricted stock units covering 11,288 and 30,129 shares of Precision Biosciences common stock in this initial ownership report to the SEC.
How do Mei Zhang Lu’s 16,932 RSUs in DTIL granted July 24, 2025 vest?
A grant of 16,932 RSUs made to Mei Zhang Lu on July 24, 2025 vests in three substantially equal annual installments, beginning on February 24, 2026, subject to her continued service with Precision Biosciences through each applicable vesting date.
What are the vesting terms of the 30,129 RSUs reported by Mei Zhang Lu in DTIL?
Mei Zhang Lu was granted 30,129 RSUs on June 1, 2026. These units vest in three substantially equal annual installments, beginning on February 22, 2027, conditioned on her continued service to Precision Biosciences through each scheduled vesting date.
Are Mei Zhang Lu’s DTIL stock options vested and when do they expire?
All reported employee stock options held by Mei Zhang Lu are fully vested and exercisable as of the report date, with expiration dates on 2029-05-01, 2030-08-20, 2031-06-06 and 2032-03-02 for the respective option grants.
What does each RSU reported by Mei Zhang Lu in DTIL represent?
Each restricted stock unit held by Mei Zhang Lu represents a contingent right to receive one share of Precision Biosciences common stock, meaning shares are delivered only upon satisfaction of the applicable vesting conditions described in the RSU award terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
